Evidence map›Paper›PMID 38792879›Full record

ReviewMedicina (Kaunas, Lithuania)2024

Multimodal Treatment of Metastatic Rectal Cancer in a Young Patient: Case Report and Literature Review.

Ionuț Popescu, Ana-Maria Dudău, Simona Dima, Vlad Herlea, Vlad M Croitoru, Ioana Mihaela Dinu, Monica Miron, Ioana Lupescu, Irina M Croitoru-Cazacu, Radu Dumitru and 1 more

Abstract readCase ReportsReview
In one paragraph

Review in Medicina (Kaunas, Lithuania), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ionuț PopescuFaculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.ORCID 0009-0001-5499-5926
Ana-Maria DudăuFaculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.
Simona DimaFaculty of Medicine, University of Medicine and Pharmacy Carol Davila, 020021 Bucharest, Romania.ORCID 0000-0001-5275-8938
Vlad HerleaFaculty of Medicine, University of Medicine and Pharmacy Carol Davila, 020021 Bucharest, Romania.ORCID 0000-0002-0125-7815
Vlad M CroitoruFaculty of Medicine, Titu Maiorescu University, 040441 Bucharest, Romania.ORCID 0000-0002-4708-6265
Ioana Mihaela DinuMedical Oncology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.ORCID 0000-0003-3464-8940
Monica MironMedical Oncology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.
Ioana LupescuFaculty of Medicine, University of Medicine and Pharmacy Carol Davila, 020021 Bucharest, Romania.
Irina M Croitoru-CazacuMedical Oncology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.ORCID 0000-0001-7483-7194
Radu DumitruFaculty of Medicine, University of Medicine and Pharmacy Carol Davila, 020021 Bucharest, Romania.ORCID 0000-0002-5618-5927
Adina Emilia CroitoruMedical Oncology Department, Fundeni Clinical Institute, 022328 Bucharest, Romania.ORCID 0000-0003-4216-6570

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic colorectal cancer requires a multidisciplinary and individualized approach. Herein, we reported the case of a young woman diagnosed with metastatic rectal cancer who received an individualized multimodal treatment strategy that resulted in a remarkable survival. There were several particular aspects of this case, such as the early onset of the disease, the successful use of conversion therapy, the application of liquid biopsy to guide treatment, and the specific nature of the bone metastasis. To offer more insights for navigating such challenges in patients with metastatic colorectal cancer, we have conducted a literature review to find more data related to the particularities of this case. The incidence of early onset colorectal cancer is on the rise. Data suggests that it differs from older-onset colorectal cancer in terms of its pathological, epidemiological, anatomical, metabolic, and biological characteristics. Conversion therapy and surgical intervention provide an opportunity for cure and improve outcomes in metastatic colorectal cancer. It is important to approach each case individually, as every patient with limited liver disease should be considered as a candidate for secondary resection. Moreover, liquid biopsy has an important role in the individualized management of metastatic colorectal cancer patients, as it offers additional information for treatment decisions.

Indexed as

Rectal NeoplasmsAdultAntineoplastic Combined Chemotherapy ProtocolsBone NeoplasmsCombined Modality TherapyFemaleFluorouracilHumansNeoplasm MetastasisFluorouracilbone metastasesconversion therapyearly onset colorectal cancerliquid biopsyliver metastasesmetastatic rectal cancer

Identifiers

PMID38792879
PMCPMC11123219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.